Symbol:
Ciita
Name:
class II, major histocompatibility complex, transactivator
RGD ID:
619813
Description:
Predicted to enable DNA-binding transcription factor binding activity and transcription cis-regulatory region binding activity. Involved in several processes, including cellular response to electrical stimulus; cellular response to exogenous dsRNA; and regulation of transcription by RNA polymerase II. Located in cell surface. Used to study periapical periodontitis. Human ortholog(s) of this gene implicated in Addison's disease; MHC class II deficiency; autoimmune disease (multiple); and myocardial infarction. Orthologous to human CIITA (class II major histocompatibility complex transactivator); PARTICIPATES IN antigen processing and presentation pathway; influenza A pathway; primary immunodeficiency pathway; INTERACTS WITH 17beta-estradiol; 17beta-estradiol 3-benzoate; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
C2ta; class II transactivator; MHC class II transactivator; MHC class II transactivator type IV; Mhc2ta
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
CIITA (class II major histocompatibility complex transactivator)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Ciita (class II transactivator)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Ciita (class II major histocompatibility complex transactivator)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
CIITA (class II major histocompatibility complex transactivator)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
CIITA (class II major histocompatibility complex transactivator)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Ciita (class II major histocompatibility complex transactivator)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
CIITA (class II major histocompatibility complex transactivator)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
CIITA (class II major histocompatibility complex transactivator)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Ciita (class II major histocompatibility complex transactivator)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
SPAG5 (sperm associated antigen 5)
HGNC
OMA
Alliance orthologs 3
Mus musculus (house mouse):
Ciita (class II transactivator)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
CIITA (class II major histocompatibility complex transactivator)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
ciita (class II, major histocompatibility complex, transactivator)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
ciita
Alliance
DIOPT (OrthoFinder|PANTHER)
Candidate Gene For:
Neuinf3
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 5,646,854 - 5,694,393 (-) NCBI GRCr8 mRatBN7.2 10 5,139,947 - 5,187,493 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 5,140,178 - 5,187,440 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 9,836,592 - 9,883,847 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 9,357,706 - 9,404,970 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 4,995,977 - 5,043,240 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 5,212,621 - 5,260,641 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 5,213,350 - 5,260,608 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 4,036,437 - 4,083,966 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 5,087,174 - 5,133,418 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 5,087,173 - 5,133,418 (-) NCBI Celera 10 4,158,435 - 4,205,434 (-) NCBI Celera Cytogenetic Map 10 q11 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Ciita Rat 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CIITA mRNA CTD PMID:32741896 Ciita Rat 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CIITA mRNA CTD PMID:32741896 Ciita Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ciita (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CIITA mRNA CTD PMID:26377647 Ciita Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CIITA mRNA CTD PMID:32109520 and PMID:34747641 Ciita Rat 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile affects expression ISO CIITA (Homo sapiens) 6480464 Verapamil affects the expression of CIITA mRNA CTD PMID:25811541 Ciita Rat 4,4'-sulfonyldiphenol affects methylation ISO Ciita (Mus musculus) 6480464 bisphenol S affects the methylation of CIITA gene CTD PMID:31683443 Ciita Rat 4-hydroxyphenyl retinamide decreases expression ISO Ciita (Mus musculus) 6480464 Fenretinide results in decreased expression of CIITA mRNA CTD PMID:28973697 Ciita Rat 5-aza-2'-deoxycytidine multiple interactions ISO CIITA (Homo sapiens) 6480464 Decitabine promotes the reaction [IFNG protein results in increased expression of CIITA mRNA] CTD PMID:16650406 Ciita Rat 5-azacytidine multiple interactions ISO CIITA (Homo sapiens) 6480464 [Azacitidine promotes the reaction [IFNG protein results in increased expression of CIITA mRNA]] which results in increased expression of HLA-DRA protein and [Azacitidine results in decreased methylation of CIITA promoter] promotes the reaction [IFNG protein results in increased expression of CIITA mRNA] CTD PMID:18829986 Ciita Rat 5-azacytidine increases expression ISO CIITA (Homo sapiens) 6480464 Azacitidine results in increased expression of CIITA mRNA CTD PMID:20823114 Ciita Rat 9-cis-retinoic acid increases expression ISO CIITA (Homo sapiens) 6480464 Alitretinoin results in increased expression of CIITA mRNA CTD PMID:17229644 Ciita Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of CIITA mRNA CTD PMID:31881176 Ciita Rat aflatoxin B1 increases methylation ISO CIITA (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of CIITA gene CTD PMID:27153756 Ciita Rat aflatoxin B1 decreases methylation ISO CIITA (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of CIITA intron CTD PMID:30157460 Ciita Rat Aflatoxin B2 alpha decreases methylation ISO CIITA (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of CIITA intron CTD PMID:30157460 Ciita Rat all-trans-retinoic acid increases expression ISO CIITA (Homo sapiens) 6480464 Tretinoin results in increased expression of CIITA mRNA CTD PMID:17229644 Ciita Rat all-trans-retinoic acid decreases expression ISO Ciita (Mus musculus) 6480464 Tretinoin results in decreased expression of CIITA mRNA CTD PMID:36189433 Ciita Rat all-trans-retinoic acid multiple interactions ISO Ciita (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CIITA mRNA CTD PMID:36189433 Ciita Rat allethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CIITA mRNA more ... CTD PMID:33051911 more ... Ciita Rat alpha-Zearalanol increases expression EXP 6480464 Zeranol results in increased expression of CIITA mRNA CTD PMID:35163327 Ciita Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CIITA mRNA CTD PMID:16483693 Ciita Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of CIITA mRNA CTD PMID:30779732 Ciita Rat antirheumatic drug decreases expression ISO CIITA (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of CIITA mRNA CTD PMID:24449571 Ciita Rat arsane increases methylation ISO CIITA (Homo sapiens) 6480464 Arsenic results in increased methylation of CIITA gene CTD PMID:24525453 Ciita Rat arsane affects methylation ISO CIITA (Homo sapiens) 6480464 Arsenic affects the methylation of CIITA gene CTD PMID:25304211 Ciita Rat arsenic atom increases methylation ISO CIITA (Homo sapiens) 6480464 Arsenic results in increased methylation of CIITA gene CTD PMID:24525453 Ciita Rat arsenic atom affects methylation ISO CIITA (Homo sapiens) 6480464 Arsenic affects the methylation of CIITA gene CTD PMID:25304211 Ciita Rat arsenous acid decreases expression ISO CIITA (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of CIITA mRNA CTD PMID:20458559 Ciita Rat atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of CIITA mRNA CTD PMID:36841081 Ciita Rat benzo[a]pyrene decreases expression ISO Ciita (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CIITA mRNA CTD PMID:21569818 Ciita Rat benzo[a]pyrene affects methylation ISO CIITA (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CIITA promoter CTD PMID:27901495 Ciita Rat benzo[a]pyrene decreases methylation ISO CIITA (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of CIITA exon CTD PMID:27901495 Ciita Rat benzo[a]pyrene multiple interactions ISO Ciita (Mus musculus) 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CIITA mRNA] CTD PMID:22228805 Ciita Rat bis(2-chloroethyl) sulfide decreases expression ISO Ciita (Mus musculus) 6480464 Mustard Gas results in decreased expression of CIITA mRNA CTD PMID:26392148 Ciita Rat bis(2-ethylhexyl) phthalate increases expression ISO Ciita (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of CIITA mRNA CTD PMID:28085963 Ciita Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CIITA mRNA CTD PMID:25181051 Ciita Rat bisphenol A increases expression ISO Ciita (Mus musculus) 6480464 bisphenol A results in increased expression of CIITA mRNA CTD PMID:32156529 Ciita Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CIITA mRNA CTD PMID:32145629 Ciita Rat bisphenol A decreases expression ISO Ciita (Mus musculus) 6480464 bisphenol A results in decreased expression of CIITA mRNA CTD PMID:30303745 Ciita Rat bisphenol A affects methylation ISO Ciita (Mus musculus) 6480464 bisphenol A affects the methylation of CIITA promoter CTD PMID:27334623 Ciita Rat bisphenol F increases expression ISO Ciita (Mus musculus) 6480464 bisphenol F results in increased expression of CIITA mRNA CTD PMID:38685157 Ciita Rat buta-1,3-diene decreases expression ISO Ciita (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of CIITA mRNA CTD PMID:29038090 Ciita Rat butanal decreases expression ISO CIITA (Homo sapiens) 6480464 butyraldehyde results in decreased expression of CIITA mRNA CTD PMID:26079696 Ciita Rat capsaicin multiple interactions ISO Ciita (Mus musculus) 6480464 Capsaicin inhibits the reaction [IFNG protein results in increased expression of CIITA mRNA] CTD PMID:19825429 Ciita Rat carbon nanotube decreases expression ISO Ciita (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of CIITA mRNA CTD PMID:25554681 Ciita Rat chloroprene decreases expression ISO Ciita (Mus musculus) 6480464 Chloroprene results in decreased expression of CIITA mRNA CTD PMID:23125180 Ciita Rat copper(II) chloride decreases expression ISO CIITA (Homo sapiens) 6480464 cupric chloride results in decreased expression of CIITA mRNA CTD PMID:38568856 Ciita Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CIITA mRNA CTD PMID:27523638 Ciita Rat cyhalothrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CIITA mRNA more ... CTD PMID:33051911 more ... Ciita Rat cypermethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CIITA mRNA more ... CTD PMID:33051911 more ... Ciita Rat diarsenic trioxide decreases expression ISO CIITA (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of CIITA mRNA CTD PMID:20458559 Ciita Rat dichloromethane increases expression EXP 6480464 Methylene Chloride results in increased expression of CIITA mRNA CTD PMID:20955722 Ciita Rat dimethyl fumarate multiple interactions ISO CIITA (Homo sapiens) 6480464 Dimethyl Fumarate inhibits the reaction [IFNG protein results in increased expression of CIITA mRNA] CTD PMID:30021835 Ciita Rat dimethylarsinic acid multiple interactions ISO Ciita (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIITA mRNA CTD PMID:34876320 Ciita Rat ethylbenzene increases expression EXP 6480464 ethylbenzene results in increased expression of CIITA mRNA CTD PMID:20955722 Ciita Rat fenvalerate multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CIITA mRNA more ... CTD PMID:33051911 more ... Ciita Rat folic acid increases expression ISO Ciita (Mus musculus) 6480464 Folic Acid results in increased expression of CIITA mRNA CTD PMID:25629700 Ciita Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CIITA mRNA CTD PMID:22061828 Ciita Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CIITA mRNA CTD PMID:33387578 Ciita Rat lipopolysaccharide multiple interactions ISO CIITA (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CIITA mRNA] CTD PMID:35811015 Ciita Rat lipopolysaccharide increases expression ISO CIITA (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of CIITA mRNA CTD PMID:35811015 Ciita Rat manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of CIITA mRNA CTD PMID:28801915 Ciita Rat melphalan decreases expression ISO CIITA (Homo sapiens) 6480464 Melphalan results in decreased expression of CIITA mRNA CTD PMID:22363485 Ciita Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of CIITA gene CTD PMID:35440735 Ciita Rat methyl methanesulfonate decreases expression ISO CIITA (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of CIITA mRNA CTD PMID:23649840 Ciita Rat methylarsonic acid multiple interactions ISO Ciita (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIITA mRNA CTD PMID:34876320 Ciita Rat mono(2-ethylhexyl) phthalate multiple interactions ISO Ciita (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CIITA mRNA CTD PMID:36189433 Ciita Rat mono(2-ethylhexyl) phthalate decreases expression ISO Ciita (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of CIITA mRNA CTD PMID:36189433 Ciita Rat nevirapine increases expression ISO CIITA (Homo sapiens) 6480464 Nevirapine results in increased expression of CIITA CTD PMID:26626330 Ciita Rat nickel atom increases expression ISO CIITA (Homo sapiens) 6480464 Nickel results in increased expression of CIITA mRNA CTD PMID:24768652 and PMID:25583101 Ciita Rat nitrates multiple interactions ISO Ciita (Mus musculus) 6480464 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CIITA mRNA CTD PMID:35964746 Ciita Rat Nor-9-carboxy-delta9-THC multiple interactions ISO CIITA (Homo sapiens) 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of CIITA gene CTD PMID:30521419 Ciita Rat ozone multiple interactions ISO Ciita (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CIITA mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CIITA mRNA CTD PMID:34911549 Ciita Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CIITA mRNA CTD PMID:33387578 Ciita Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CIITA mRNA CTD PMID:32680482 Ciita Rat perfluorononanoic acid decreases expression ISO CIITA (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of CIITA mRNA CTD PMID:25812627 Ciita Rat perfluorooctane-1-sulfonic acid decreases expression ISO CIITA (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of CIITA mRNA CTD PMID:25812627 Ciita Rat perfluorooctanoic acid decreases expression ISO CIITA (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of CIITA mRNA CTD PMID:25812627 Ciita Rat pirinixic acid decreases expression ISO Ciita (Mus musculus) 6480464 pirinixic acid results in decreased expression of CIITA mRNA CTD PMID:17426115 Ciita Rat pregnenolone 16alpha-carbonitrile decreases expression ISO Ciita (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of CIITA mRNA CTD PMID:22698814 Ciita Rat pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of CIITA mRNA CTD PMID:34896426 and PMID:36053783 Ciita Rat ritonavir increases expression ISO CIITA (Homo sapiens) 6480464 Ritonavir results in increased expression of CIITA CTD PMID:26626330 Ciita Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO CIITA (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CIITA mRNA] CTD PMID:35811015 Ciita Rat simvastatin multiple interactions ISO CIITA (Homo sapiens) 6480464 Simvastatin inhibits the reaction [IFNG results in increased expression of CIITA protein] CTD PMID:11219190 Ciita Rat sodium arsenate multiple interactions ISO Ciita (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIITA mRNA CTD PMID:34876320 Ciita Rat sodium arsenite affects methylation ISO CIITA (Homo sapiens) 6480464 sodium arsenite affects the methylation of CIITA gene CTD PMID:28589171 Ciita Rat sodium arsenite multiple interactions ISO Ciita (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CIITA mRNA CTD PMID:34876320 Ciita Rat sodium arsenite increases expression ISO CIITA (Homo sapiens) 6480464 sodium arsenite results in increased expression of CIITA mRNA CTD PMID:34032870 Ciita Rat sodium arsenite decreases expression ISO CIITA (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CIITA mRNA CTD PMID:32844245 Ciita Rat sodium dichromate decreases expression ISO Ciita (Mus musculus) 6480464 sodium bichromate results in decreased expression of CIITA mRNA CTD PMID:22155349 Ciita Rat sodium dichromate increases expression ISO Ciita (Mus musculus) 6480464 sodium bichromate results in increased expression of CIITA mRNA CTD PMID:22155349 Ciita Rat T-2 toxin increases expression ISO Ciita (Mus musculus) 6480464 T-2 Toxin results in increased expression of CIITA mRNA CTD PMID:36775139 Ciita Rat tamibarotene increases expression ISO CIITA (Homo sapiens) 6480464 tamibarotene results in increased expression of CIITA mRNA CTD PMID:17229644 Ciita Rat testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CIITA mRNA CTD PMID:32741896 Ciita Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CIITA mRNA CTD PMID:34492290 Ciita Rat titanium dioxide increases expression ISO Ciita (Mus musculus) 6480464 titanium dioxide results in increased expression of CIITA mRNA CTD PMID:23557971 and PMID:35295148 Ciita Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CIITA mRNA CTD PMID:20955722 Ciita Rat triptonide increases expression ISO Ciita (Mus musculus) 6480464 triptonide results in increased expression of CIITA mRNA CTD PMID:33045310 Ciita Rat tungsten decreases expression ISO Ciita (Mus musculus) 6480464 Tungsten results in decreased expression of CIITA mRNA CTD PMID:30912803 Ciita Rat valproic acid increases methylation ISO CIITA (Homo sapiens) 6480464 Valproic Acid results in increased methylation of CIITA gene CTD PMID:29154799 Ciita Rat verapamil affects expression ISO CIITA (Homo sapiens) 6480464 Verapamil affects the expression of CIITA mRNA CTD PMID:25811541 Ciita Rat zinc atom affects expression ISO CIITA (Homo sapiens) 6480464 Zinc affects the expression of CIITA mRNA CTD PMID:16979875 Ciita Rat zinc(0) affects expression ISO CIITA (Homo sapiens) 6480464 Zinc affects the expression of CIITA mRNA CTD PMID:16979875 Ciita Rat zoledronic acid increases expression ISO CIITA (Homo sapiens) 6480464 zoledronic acid results in increased expression of CIITA mRNA CTD PMID:24714768
Imported Annotations - KEGG (archival)
17beta-estradiol (EXP) 17beta-estradiol 3-benzoate (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 5-aza-2'-deoxycytidine (ISO) 5-azacytidine (ISO) 9-cis-retinoic acid (ISO) acetamide (EXP) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) all-trans-retinoic acid (ISO) allethrin (EXP) alpha-Zearalanol (EXP) ammonium chloride (EXP) amphetamine (EXP) antirheumatic drug (ISO) arsane (ISO) arsenic atom (ISO) arsenous acid (ISO) atrazine (EXP) benzo[a]pyrene (ISO) bis(2-chloroethyl) sulfide (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) buta-1,3-diene (ISO) butanal (ISO) capsaicin (ISO) carbon nanotube (ISO) chloroprene (ISO) copper(II) chloride (ISO) Cuprizon (EXP) cyhalothrin (EXP) cypermethrin (EXP) diarsenic trioxide (ISO) dichloromethane (EXP) dimethyl fumarate (ISO) dimethylarsinic acid (ISO) ethylbenzene (EXP) fenvalerate (EXP) folic acid (ISO) gentamycin (EXP) lipopolysaccharide (ISO) manganese(II) chloride (EXP) melphalan (ISO) methoxychlor (EXP) methyl methanesulfonate (ISO) methylarsonic acid (ISO) mono(2-ethylhexyl) phthalate (ISO) nevirapine (ISO) nickel atom (ISO) nitrates (ISO) Nor-9-carboxy-delta9-THC (ISO) ozone (ISO) paracetamol (EXP) paraquat (EXP) perfluorononanoic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (ISO) pirinixic acid (ISO) pregnenolone 16alpha-carbonitrile (ISO) pyrethrins (EXP) ritonavir (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) simvastatin (ISO) sodium arsenate (ISO) sodium arsenite (ISO) sodium dichromate (ISO) T-2 toxin (ISO) tamibarotene (ISO) testosterone (EXP) thioacetamide (EXP) titanium dioxide (ISO) trichloroethene (EXP) triptonide (ISO) tungsten (ISO) valproic acid (ISO) verapamil (ISO) zinc atom (ISO) zinc(0) (ISO) zoledronic acid (ISO)
Biological Process
cellular response to electrical stimulus (IEP) cellular response to exogenous dsRNA (IEP) cellular response to type II interferon (IEP) host-mediated suppression of symbiont invasion (ISO) negative regulation of collagen biosynthetic process (ISO) negative regulation of DNA-templated transcription (IEA,ISO) negative regulation of transcription by RNA polymerase II (IDA,ISO) positive regulation of MHC class I biosynthetic process (IBA,ISO) positive regulation of MHC class II biosynthetic process (IBA,IDA,IEP,ISO) positive regulation of transcription by RNA polymerase II (IBA,IDA,IEA,ISO) regulation of DNA-templated transcription (IEA) response to antibiotic (ISO) response to type II interferon (IEA,ISO) type II interferon-mediated signaling pathway (ISO)
1.
Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups.
Akkad DA, etal., Int J Immunogenet. 2006 Feb;33(1):59-61.
2.
Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A.
Bontron S, etal., Hum Genet. 1997 Apr;99(4):541-6.
3.
Successful treatment of experimental autoimmune myocarditis by adenovirus-mediated gene transfer of antisense CIITA.
Cai G, etal., J Mol Cell Cardiol. 2005 Apr;38(4):593-605.
4.
mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging.
Frank MG, etal., Neurobiol Aging. 2006 May;27(5):717-22.
5.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
6.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
7.
Vra4 congenic rats with allelic differences in the class II transactivator gene display altered susceptibility to experimental autoimmune encephalomyelitis.
Harnesk K, etal., J Immunol. 2008 Mar 1;180(5):3289-96.
8.
Overexpression of CIITA in T cells aggravates Th2-mediated colitis in mice.
Kim TW, etal., J Korean Med Sci. 2006 Oct;21(5):877-82.
9.
Single nucleotide polymorphisms in the gene encoding the major histocompatibility complex class II transactivator (CIITA) in systemic lupus erythematosus.
Koizumi K, etal., Ann Rheum Dis. 2005 Jun;64(6):947-50.
10.
Failure of MHC class II expression in neonatal alveolar macrophages: potential role of class II transactivator.
Lee PT, etal., Eur J Immunol 2001 Aug;31(8):2347-56.
11.
Major histocompatibility complex class II transactivator inhibits cysteine-rich 61 expression in osteoblastic cells and its implication in the pathogenesis of periapical lesions.
Lee YL, etal., J Endod. 2010 Jun;36(6):1021-5. doi: 10.1016/j.joen.2010.03.009. Epub 2010 Apr 21.
12.
Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality.
Lindholm E, etal., PLoS One. 2006 Dec 20;1:e64.
13.
A polymorphic variant in the MHC2TA gene is not associated with systemic lupus erythematosus.
Linga-Reddy MV, etal., Tissue Antigens. 2007 Nov;70(5):412-4. Epub 2007 Aug 17.
14.
Chromosomal region 16p13: further evidence of increased predisposition to immune diseases.
Martinez A, etal., Ann Rheum Dis. 2010 Jan;69(1):309-11. Epub .
15.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
16.
Class II transactivator suppresses transcription of thyroid-specific genes.
Mori-Aoki A, etal., Biochem Biophys Res Commun 2000 Nov 11;278(1):58-62.
17.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
18.
The MHC2TA-168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies.
O'Doherty C, etal., Tissue Antigens. 2007 Sep;70(3):247-51.
19.
Protective effect of A at position - 168 in the type III promoter of the MHCIITA gene in systemic lupus erythematosus.
Okamoto H, etal., Ann Rheum Dis. 2007 Sep;66(9):1263-4.
20.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
21.
Susceptibility of mice deficient in the MHC class II transactivator to infection with Mycobacterium tuberculosis.
Repique CJ, etal., Scand J Immunol. 2003 Jul;58(1):15-22.
22.
GOA pipeline
RGD automated data pipeline
23.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
24.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
25.
Comprehensive gene review and curation
RGD comprehensive gene curation
26.
In vivo class II transactivator expression in mice is induced by a non-interferon-gamma mechanism in response to local injury.
Sims TN, etal., Transplantation. 1997 Dec 27;64(12):1657-64.
27.
Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency.
Skinningsrud B, etal., J Clin Endocrinol Metab. 2008 Sep;93(9):3310-7. Epub 2008 Jul 1.
28.
Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides.
Suzuki K, etal., Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2285-90.
29.
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
Swanberg M, etal., Nat Genet 2005 May;37(5):486-94. Epub 2005 Apr 10.
30.
Differential usage of class II transactivator promoters PI and PIV during inflammation and injury in kidney.
Takeuchi O, etal., J Am Soc Nephrol. 2003 Nov;14(11):2823-32.
31.
Mutation in the class II trans-activator leading to a mild immunodeficiency.
Wiszniewski W, etal., J Immunol. 2001 Aug 1;167(3):1787-94.
32.
Downregulating immunogenicity of Schwann cells via inhibiting a potential target of class II transactivator (CIITA) gene.
Yang Y, etal., Biosci Trends. 2013 Feb;7(1):50-5.
33.
Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex.
Zuvich RL, etal., Hum Mol Genet. 2011 Sep 1;20(17):3517-24. Epub 2011 Jun 8.
Ciita (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 5,646,854 - 5,694,393 (-) NCBI GRCr8 mRatBN7.2 10 5,139,947 - 5,187,493 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 5,140,178 - 5,187,440 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 9,836,592 - 9,883,847 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 9,357,706 - 9,404,970 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 4,995,977 - 5,043,240 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 5,212,621 - 5,260,641 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 5,213,350 - 5,260,608 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 4,036,437 - 4,083,966 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 5,087,174 - 5,133,418 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 5,087,173 - 5,133,418 (-) NCBI Celera 10 4,158,435 - 4,205,434 (-) NCBI Celera Cytogenetic Map 10 q11 NCBI
CIITA (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 16 10,866,206 - 10,943,021 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 16 10,866,222 - 10,943,021 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 16 10,971,055 - 11,030,251 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 16 10,878,556 - 10,926,341 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 16 10,878,539 - 10,933,676 NCBI Celera 16 11,140,481 - 11,188,432 (+) NCBI Celera Cytogenetic Map 16 p13.13 NCBI HuRef 16 10,888,898 - 10,936,424 (+) NCBI HuRef CHM1_1 16 10,970,985 - 11,018,760 (+) NCBI CHM1_1 T2T-CHM13v2.0 16 10,902,173 - 10,978,992 (+) NCBI T2T-CHM13v2.0
Ciita (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 16 10,297,877 - 10,348,928 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 16 10,297,923 - 10,346,282 (+) Ensembl GRCm39 Ensembl GRCm38 16 10,480,014 - 10,531,064 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 16 10,480,059 - 10,528,418 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 16 10,488,372 - 10,527,657 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 16 10,401,857 - 10,441,142 (+) NCBI MGSCv36 mm8 Celera 16 11,120,578 - 11,160,248 (+) NCBI Celera Cytogenetic Map 16 A1 NCBI cM Map 16 5.65 NCBI
Ciita (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955442 7,603,893 - 7,647,624 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955442 7,600,903 - 7,647,619 (-) NCBI ChiLan1.0 ChiLan1.0
CIITA (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 18 11,426,662 - 11,492,167 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 16 15,201,913 - 15,267,425 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 16 9,819,440 - 9,885,379 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 16 11,041,434 - 11,090,485 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 16 11,041,434 - 11,090,485 (+) Ensembl panpan1.1 panPan2
CIITA (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 6 31,774,486 - 31,837,025 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 6 31,774,609 - 31,836,820 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 6 33,156,962 - 33,219,510 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 6 31,956,967 - 32,019,399 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 6 31,956,967 - 31,996,000 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 6 31,770,183 - 31,832,926 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 6 31,644,456 - 31,706,901 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 6 32,068,973 - 32,131,721 (-) NCBI UU_Cfam_GSD_1.0
Ciita (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
CIITA (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 3 32,172,214 - 32,230,780 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 3 32,171,706 - 32,230,775 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 3 33,109,119 - 33,117,697 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
CIITA (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 5 10,341,690 - 10,401,988 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 5 10,372,344 - 10,400,451 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666068 19,764,657 - 19,814,384 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Ciita (Heterocephalus glaber - naked mole-rat)
.
Assembly: RGSC_v3.4
Assembly: Rnor_5.0
Assembly: Rnor_6.0
Predicted Target Of
Count of predictions: 245 Count of miRNA genes: 155 Interacting mature miRNAs: 164 Transcripts: ENSRNOT00000003572 Prediction methods: Microtar, Miranda, Rnahybrid Result types: miRGate_prediction
634329 Pia15 Pristane induced arthritis QTL 15 3.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 1 24158324 Rat 2293680 Bss40 Bone structure and strength QTL 40 5.66 0.0001 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 10 1 35225947 Rat 7387235 Uae41 Urinary albumin excretion QTL 41 5.26 0.1874 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 10 1 29497586 Rat 10401803 Kidm50 Kidney mass QTL 50 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 10 418344 45418344 Rat 737820 Alc9 Alcohol consumption QTL 9 2.2 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 10 5144027 19233348 Rat 1576304 Schws7 Schwannoma susceptibility QTL 7 0.0115 nervous system integrity trait (VT:0010566) percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) 10 4765527 19816042 Rat 7411611 Foco17 Food consumption QTL 17 18.7 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 10 1 42315980 Rat 631554 Bp133 Blood pressure QTL 133 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 743364 63851208 Rat 1549898 Neuinf3 Neuroinflammation QTL 3 26.4 nervous system integrity trait (VT:0010566) MHC Class II RT1A-positive spinal cord ventral horn area to total spinal cord ventral horn area ratio (CMO:0001980) 10 3406320 5387112 Rat 631828 Alc5 Alcohol consumption QTL 5 2.4 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 10 5144027 17245662 Rat 634327 Hc4 Hypercalciuria QTL 4 2.4 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 10 1 38328221 Rat 70223 Bp57 Blood pressure QTL 57 5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 1 80676123 Rat
D10Mgh25
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 5,144,027 - 5,144,168 (+) MAPPER mRatBN7.2 Rnor_6.0 10 5,217,199 - 5,217,339 NCBI Rnor6.0 Rnor_5.0 10 4,040,517 - 4,040,657 UniSTS Rnor5.0 RGSC_v3.4 10 5,090,008 - 5,090,149 RGD RGSC3.4 RGSC_v3.4 10 5,090,009 - 5,090,149 UniSTS RGSC3.4 RGSC_v3.1 10 5,090,008 - 5,090,149 RGD Celera 10 4,162,284 - 4,162,424 UniSTS Cytogenetic Map 10 q11 UniSTS
D10Got7
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 5,182,151 - 5,182,387 (+) MAPPER mRatBN7.2 Rnor_6.0 10 5,255,322 - 5,255,555 NCBI Rnor6.0 Rnor_5.0 10 4,078,682 - 4,078,915 UniSTS Rnor5.0 RGSC_v3.4 10 5,128,131 - 5,128,365 RGD RGSC3.4 RGSC_v3.4 10 5,128,132 - 5,128,365 UniSTS RGSC3.4 RGSC_v3.1 10 5,128,131 - 5,128,365 RGD Celera 10 4,200,148 - 4,200,381 UniSTS RH 2.0 Map 10 0.0 RGD Cytogenetic Map 10 q11 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
39
89
83
82
51
25
51
6
200
87
69
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000003572 ⟹ ENSRNOP00000003572
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 5,140,178 - 5,187,440 (-) Ensembl Rnor_6.0 Ensembl 10 5,213,350 - 5,260,608 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000085310 ⟹ ENSRNOP00000075087
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 5,140,178 - 5,180,166 (-) Ensembl Rnor_6.0 Ensembl 10 5,213,350 - 5,253,336 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000085479 ⟹ ENSRNOP00000069553
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 5,140,178 - 5,168,808 (-) Ensembl Rnor_6.0 Ensembl 10 5,213,350 - 5,251,809 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000095982 ⟹ ENSRNOP00000076804
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 5,140,178 - 5,168,808 (-) Ensembl
RefSeq Acc Id:
NM_001270803 ⟹ NP_001257732
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 5,647,085 - 5,687,070 (-) NCBI mRatBN7.2 10 5,140,178 - 5,180,166 (-) NCBI Rnor_6.0 10 5,213,350 - 5,253,336 (-) NCBI Rnor_5.0 10 4,036,437 - 4,083,966 (-) NCBI Celera 10 4,158,435 - 4,198,162 (-) NCBI
Sequence:
TGAGGCTGCCTGCTTCCCACCTGGGCATCTGAGGACCGTCTTGGAGACATTTGGCACACCAGCTGGACCACAGACACTGCTGCATCACTCCTCTCTTTACATCATGCGCTGCCAGGTTCCCGGCCCTT CTGGGTCTTACCTGCAAGGCCATACTCTGTGTGCCACCATGGAGCTGGGGTCTCCAGAGGGCAGCTACCTGGAGCTCCTTAACAGTGATGCTGACCCCCTACACCTCTACCACCTCTATGACCAGATG GACCTTGCTGGGGAGGAAGAGATCGAACTCAACTCAGAGACAGACATGGACACCATCAACTGTGACCAGTTCAGCAAGCTGTTGCAGGATATGGAAATGGATGAAGAGACCCGGGAGGCCTATGCCAA TATCGCGGAACTGGATCAGTACGTGTTCCAGGATACCCAGCTGGAGGGCCTGAGCAAGGACCTCTTCATACAGCACATTGGACCAGAGGAAGGCTTTGGTGAGAACGTAGAGGGCCCTGCAGAATCAG GAGAGAAGCCTCAGAAGAGACGCTTCCCAGAAGAGCATGCTATGGACTCAAAGCACAGGAAACTAGTGCCTCCCTCTAGGACCTCACTGAACTATTTGGATCTCCCCGCTGGGCATATCCAGATCTTC ACCACTCTGCCCCAGGGACTCTGGCAAATCTCAGGGGTTGGCACAGGGCTCTCCAGTGTCCTAGTCTACCACGGTGAGATGCCCCAGGTCAACCAATTACTCTCTTCAAGCAGCCCCACTGTCCCCAG TCTCCCCGAGTCCCCAGACCGGCCTGGCTCCACCAGCCCCTTCGCGCCATCCACAGCTGACCTGCCCGGCATGCCTGAACCTGCTCTGACCTCCCGTGTAAATGAGACAGAGGACACAACACCCCCCT CCCCATGCCAAGAGGATCCCGAGCCTTCCATCAAGCTTCCAAAATGGCCAGAGTCCGTGGAGCGGTTCCAGCACTCCCTACAGGACAAGTACCAAGCACTGCCCGGGAGCCCAAGTGGTCCTCTGGTA GCCATGGAGCTGGTGCGGGCCAGGTTGGAAAGAGGTAGCAACAAGAGTCAGGAAAGGGAGCTGGCCACTCCTGACTGGACAGAGCGCCAGCTAGCCCATGGCGGTCTGGCCGAGGTACTTCGGGTTGT CGGCGACTCCAGGAGATCACGAGAGACACAGGTGGTCGCTGTGCTGGGCAAGGCTGGTCAGGGCAAGAGCCACTGGGCCAGGACAGTGAGCCACATTTGGGCACAAGGCCAGTTACCACAATATGACT TTGTCTTCTACGTCCCCTGTCAATGCTTGGATCGCCCTGGGGACACCTACCACCTGCGGGATCTGCTCTGTCCCCCGAACCTGCAGCCACTGGCCATGGATGACGAGGTCATTGATCATATTGTGAGG CAGCCGGACCGTGTTCTGCTCATCCTAGATGCTTTTGAGGAGCTAGAGGCCCAAGACAGCCTCCTGCATGGACCCTGTGGACCTCTGTCCCCAGAGCCCTGCTCCCTCCGGGGACTGCTGGCTGGGCT CTTCCAGCGTAAGCTGCTGCGAGGCTGCACCCTGCTCCTCACAGCCCGGCCCCGGGGCCGCCTGGCTCAGAGCCTGAGCAAGGCAGATGCCATCTTCGAGGTGCCCAGCTTCTCTACGAAACAGGCCC AGATCTATATGAGGCACTACTTTGAGAACTCAGGGACAGCAGGGAGTCACGACAAGGCCCTGGGCCTCCTGGAGGGCCAGCCTTTTCTCCTCACCCACAGTCACAGCCCTGTTCTGTGCAGTGCCGTG TGTCAGCTCTCCAAGGCCCTGCTGGATCAGGGCGCAGAGGCCCAGCTACCTTGCACACTCACAGGACTCTATGTTGGCCTGCTAGGCCCTGCAGCTCAGAACAGTCCTCCTGGAGCCTTAGTTGAGTT GGCCAAGCTAGCCTGGGAGCTGGGACGGAGGCACCAAAGCACCTTGCAGGAAACCCAGTTTCCATCCGTGGAAGTGAAGACCTGGGCTGTGGCCCAAGGCTTGATGCAGCAGACCACAGAGGCCCAAC TGGCTTTCTCCAGTTTTCTGCTACAGTGCTTCCTGGGTGCTGTGTGGCTGGCACAGTGCAATGAGATGAAAGACAAGGAGCTGCCACAGTACCTGGCCTTGACCCCGAGGAAGAAGCGACCCTATGAC AACTGGCTGGAGGGCGTACCACGCTTTCTGGCTGGCTTAGTTTTCCAGCCTCGAGCCCACTGCCTGGGAGCTCTGGTGGAGCCTGCAATGGCTGCAGTGGCAGATAGGAAACGGAAGGTTCTTACCAG GTACCTGAAGCGCTTGAAGCTGGGGACACTTCGGGCCGGGAGGTTGCTGGAGCTGCTACACTGTGCCCACGAAACACAGGAACCTGGTATTTGGAAGCATGTTTCACACCAGCTCCCAGGGCACCTCT CCTTCCTGGGCACACGGCTCACAGCCCCAGATGTGTATGTTCTGGGCAGGGCCTTGGAGACAGCCAGCCAGGACTTCTCCTTGGACCTTCGTCAGACTGGCATCGAGCCCTCCAGACTGGGAGACCTC GTGGGACTCAGCTGTGTCACCAGTTTCAGGGCCTCCTTGAGTGACACAATGGCATTATGGGAGTCCCTACAGCATCAGGGAGAAACCCAGCTACTCCAGGCGGCAGAGGAGAAGTTCACCATTGAGCC ATTTAAGGCCAAATCCCCAAAGGATGTGGAAGACCTGGACAGCCTTGTGCAGACCCAGAGGCTGAGAAACCCCTCAGCGGATGCAGCCAAGGATCTTCCTGCCATCCGGGACCTTAAGAAGCTAGAGT TTGCATTGGGCCCCGTCTTGGGCCCGCAGGCTTTCCCCACACTGGCCAAGATCCTTCCAGCATTCTCTTCCCTGCAGCACCTGGACCTGGACTCACTTAGCGAGAACAAGATCGGGGACAAGGGTGTG TCGAAGCTCTCAGCCACCTTCCCTCAGCTGAAGGCCCTGGAGACGCTCAACCTGTCCCAGAATAGCATCACCGATGTGGGAGCTTGCAAGCTTGCAGAAGCCCTGCCGGCCCTGGCCAAGTCCCTCCT AAGGCTGAGCTTGTACAACAACTGCATCTGTGACGAAGGGGCCAAGAGCCTGGCACGAGTGCTTCCAGACATGGTGTCCCTCCGGGTGATGGATGTCCAGTTCAACAAGTTCACGGCTGTCGGGGCCC AGCAGCTGACCTCCAGCCTTCAGAAGTGCCCTCAGGTGGAGACACTGGCAATGTGGACACCCACTATCCCCTTTGGGGTCCAGGAACACCTGCAGCAGCTGGATGCCCGGATTAGCCTGAGATGACCC TGCTGTACCCTGGACAAGCCGTACTCTGGGACACTGACCATGCTGGACCTTGAACTGGATACTGTGGACTCAGCTCTTCTGCGGGCCATATCCCAGGAGAGTCAGCATCCGATCACCCTGCCCCTGCA GGCTCAGAGTTGGGCCCTGCCTACATGAGGACTGGATACATGTCTGGTTCCTCTGCAGGCTCCAAGACCAGCTGCAGGCTCTTCTGGCACCAGCTATCTTCATGGATACCTTCATAGATGCCCCGTTC TGCATCTGTGAGCACTGGCAGACAGGCCTGGGGCTCCTTCGTGTGGGTTCACCCAGGAGGCCGAAGGCCTTCTCTTCGACATTCCAGGCCAGTGAGGAACTGAAGCATCCAAGGGCCTGCCTTCCTTG TGAGAAATCATGTCTTCCCACTGCTCCCAGCGGCCTACTGGAGGCTCTGAAGATGCCAAGGGCGATGCTGTTCTGCGACCTCTAGAGGTGACAGGGAGCCTATGGCAGCTCTTTCTACTTGTGGCACT GTTCATAAACTTTAGGTCGAAGCTGAGTCAGGCCTGGCCCAGGCCCTGCATTGAAACAAGAGCCAGGGCACGGTCCACCTCAGGGCTGCAGCGGGCAGCTCTTCTGGCCTCTCCTTCGCACTCACTAC ACTTTAAATGCACCAAGTCCCATCTGGGGACACCTTCTGTCTCATCTAATGCAAAAACATGCAAATAAACAAAACAAGAGAAATCCCAAACCAGCCAAACCACAGTAACTTAAAACAGTCCACATCTG CCCACCAGGCAGGCTCAGCCGTCTGTCTCCACCAACCAGAAGTCAGGCTGGAGTCATCTTGAGTGTGGCATGTGACACAGGTTGCTGGCTGGGAGCCCCGAGTCTTTACTGGGACAGCTGGCTGGGGC TCGTATTTTAGCTGTGTTATAGGGGGACCACCCAGAGAGGAGAAAGTGAGGAGACACAAGCCAGCAGAGACAGTCTGTAGACTGTTCAGAACAGGCCTTAAGGCCACACAGTATGGCTTCTACCACCT TCCACCGCACCCTTGTGCATACCATACAGCCCACCACCGCTGAGGCCCTGTCTTCACTGCAAAGATCTTCGTAGCTTCCGAAGATGCAGTGAAAAGCTCTTACTCCCGGACCTGAGGACTGAAGCAGT GAGCACCAGACAGTGGAGTGTTCTCTCCTGCTGCCTTGCTGCATCCTGGGAGCATCTCTGTAGCCAAGGTGGCCAGCCTTGGCTGCAGCTAGCCCAAAGAGCTTGGCAGCACCTGCGCCATTGTTCCT GTTTTCTCTGGCCACCACCTTTGAGCTCAGGCACCATTGATCCCTCCATCTGGACGGTGACAGCTTGCTTTCATGTCTTGGCAGAGGGAGCTGTCTGTGTGACTCCAGCATGCCAGCCCTGATGCCAG CAGGACTGGCATGTCCCAGGAGGTGGGAACTGGGCTAGAGGGCCTGGGGTCGGGGGTCAGGGGTCATGGCCTCTCGGAGGTGATTCTTGAAGAGGATCCTGCTGCAGCTCTTTACATAAGACCTGATA GGGCATCAGGCTCAGCGGTGGCACATGGAAGTCCCATGTATGTGACCACAAGGGGACAGCACTGAGGCACTCTCCAAGGCAGGCACCTGCTGTACCTCTGCTTTGATCTGTCTGGAGATGCCAAAATG CCTCTCATTGCTGTGTTGATGCCTGTCATCTTAATGAGTTGATTAGGTGAAGGCAGGGACATAGTAAATGCTCAACAAACCTCA
hide sequence
RefSeq Acc Id:
NM_001270804 ⟹ NP_001257733
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 5,647,085 - 5,685,543 (-) NCBI mRatBN7.2 10 5,140,178 - 5,178,639 (-) NCBI Rnor_6.0 10 5,213,350 - 5,251,809 (-) NCBI Rnor_5.0 10 4,036,437 - 4,083,966 (-) NCBI Celera 10 4,158,435 - 4,196,635 (-) NCBI
Sequence:
AAGCTCCTAGGAGCCACAGAGCTAGCGGCAGGGAGACTACCGGCAGCACTGAGGAGCGCGGGGACCCAGCCGCGGCCATACTCTGTGTGCCACCATGGAGCTGGGGTCTCCAGAGGGCAGCTACCTGG AGCTCCTTAACAGTGATGCTGACCCCCTACACCTCTACCACCTCTATGACCAGATGGACCTTGCTGGGGAGGAAGAGATCGAACTCAACTCAGAGACAGACATGGACACCATCAACTGTGACCAGTTC AGCAAGCTGTTGCAGGATATGGAAATGGATGAAGAGACCCGGGAGGCCTATGCCAATATCGCGGAACTGGATCAGTACGTGTTCCAGGATACCCAGCTGGAGGGCCTGAGCAAGGACCTCTTCATACA GCACATTGGACCAGAGGAAGGCTTTGGTGAGAACGTAGAGGGCCCTGCAGAATCAGGAGAGAAGCCTCAGAAGAGACGCTTCCCAGAAGAGCATGCTATGGACTCAAAGCACAGGAAACTAGTGCCTC CCTCTAGGACCTCACTGAACTATTTGGATCTCCCCGCTGGGCATATCCAGATCTTCACCACTCTGCCCCAGGGACTCTGGCAAATCTCAGGGGTTGGCACAGGGCTCTCCAGTGTCCTAGTCTACCAC GGTGAGATGCCCCAGGTCAACCAATTACTCTCTTCAAGCAGCCCCACTGTCCCCAGTCTCCCCGAGTCCCCAGACCGGCCTGGCTCCACCAGCCCCTTCGCGCCATCCACAGCTGACCTGCCCGGCAT GCCTGAACCTGCTCTGACCTCCCGTGTAAATGAGACAGAGGACACAACACCCCCCTCCCCATGCCAAGAGGATCCCGAGCCTTCCATCAAGCTTCCAAAATGGCCAGAGTCCGTGGAGCGGTTCCAGC ACTCCCTACAGGACAAGTACCAAGCACTGCCCGGGAGCCCAAGTGGTCCTCTGGTAGCCATGGAGCTGGTGCGGGCCAGGTTGGAAAGAGGTAGCAACAAGAGTCAGGAAAGGGAGCTGGCCACTCCT GACTGGACAGAGCGCCAGCTAGCCCATGGCGGTCTGGCCGAGGTACTTCGGGTTGTCGGCGACTCCAGGAGATCACGAGAGACACAGGTGGTCGCTGTGCTGGGCAAGGCTGGTCAGGGCAAGAGCCA CTGGGCCAGGACAGTGAGCCACATTTGGGCACAAGGCCAGTTACCACAATATGACTTTGTCTTCTACGTCCCCTGTCAATGCTTGGATCGCCCTGGGGACACCTACCACCTGCGGGATCTGCTCTGTC CCCCGAACCTGCAGCCACTGGCCATGGATGACGAGGTCATTGATCATATTGTGAGGCAGCCGGACCGTGTTCTGCTCATCCTAGATGCTTTTGAGGAGCTAGAGGCCCAAGACAGCCTCCTGCATGGA CCCTGTGGACCTCTGTCCCCAGAGCCCTGCTCCCTCCGGGGACTGCTGGCTGGGCTCTTCCAGCGTAAGCTGCTGCGAGGCTGCACCCTGCTCCTCACAGCCCGGCCCCGGGGCCGCCTGGCTCAGAG CCTGAGCAAGGCAGATGCCATCTTCGAGGTGCCCAGCTTCTCTACGAAACAGGCCCAGATCTATATGAGGCACTACTTTGAGAACTCAGGGACAGCAGGGAGTCACGACAAGGCCCTGGGCCTCCTGG AGGGCCAGCCTTTTCTCCTCACCCACAGTCACAGCCCTGTTCTGTGCAGTGCCGTGTGTCAGCTCTCCAAGGCCCTGCTGGATCAGGGCGCAGAGGCCCAGCTACCTTGCACACTCACAGGACTCTAT GTTGGCCTGCTAGGCCCTGCAGCTCAGAACAGTCCTCCTGGAGCCTTAGTTGAGTTGGCCAAGCTAGCCTGGGAGCTGGGACGGAGGCACCAAAGCACCTTGCAGGAAACCCAGTTTCCATCCGTGGA AGTGAAGACCTGGGCTGTGGCCCAAGGCTTGATGCAGCAGACCACAGAGGCCCAACTGGCTTTCTCCAGTTTTCTGCTACAGTGCTTCCTGGGTGCTGTGTGGCTGGCACAGTGCAATGAGATGAAAG ACAAGGAGCTGCCACAGTACCTGGCCTTGACCCCGAGGAAGAAGCGACCCTATGACAACTGGCTGGAGGGCGTACCACGCTTTCTGGCTGGCTTAGTTTTCCAGCCTCGAGCCCACTGCCTGGGAGCT CTGGTGGAGCCTGCAATGGCTGCAGTGGCAGATAGGAAACGGAAGGTTCTTACCAGGTACCTGAAGCGCTTGAAGCTGGGGACACTTCGGGCCGGGAGGTTGCTGGAGCTGCTACACTGTGCCCACGA AACACAGGAACCTGGTATTTGGAAGCATGTTTCACACCAGCTCCCAGGGCACCTCTCCTTCCTGGGCACACGGCTCACAGCCCCAGATGTGTATGTTCTGGGCAGGGCCTTGGAGACAGCCAGCCAGG ACTTCTCCTTGGACCTTCGTCAGACTGGCATCGAGCCCTCCAGACTGGGAGACCTCGTGGGACTCAGCTGTGTCACCAGTTTCAGGGCCTCCTTGAGTGACACAATGGCATTATGGGAGTCCCTACAG CATCAGGGAGAAACCCAGCTACTCCAGGCGGCAGAGGAGAAGTTCACCATTGAGCCATTTAAGGCCAAATCCCCAAAGGATGTGGAAGACCTGGACAGCCTTGTGCAGACCCAGAGGCTGAGAAACCC CTCAGCGGATGCAGCCAAGGATCTTCCTGCCATCCGGGACCTTAAGAAGCTAGAGTTTGCATTGGGCCCCGTCTTGGGCCCGCAGGCTTTCCCCACACTGGCCAAGATCCTTCCAGCATTCTCTTCCC TGCAGCACCTGGACCTGGACTCACTTAGCGAGAACAAGATCGGGGACAAGGGTGTGTCGAAGCTCTCAGCCACCTTCCCTCAGCTGAAGGCCCTGGAGACGCTCAACCTGTCCCAGAATAGCATCACC GATGTGGGAGCTTGCAAGCTTGCAGAAGCCCTGCCGGCCCTGGCCAAGTCCCTCCTAAGGCTGAGCTTGTACAACAACTGCATCTGTGACGAAGGGGCCAAGAGCCTGGCACGAGTGCTTCCAGACAT GGTGTCCCTCCGGGTGATGGATGTCCAGTTCAACAAGTTCACGGCTGTCGGGGCCCAGCAGCTGACCTCCAGCCTTCAGAAGTGCCCTCAGGTGGAGACACTGGCAATGTGGACACCCACTATCCCCT TTGGGGTCCAGGAACACCTGCAGCAGCTGGATGCCCGGATTAGCCTGAGATGACCCTGCTGTACCCTGGACAAGCCGTACTCTGGGACACTGACCATGCTGGACCTTGAACTGGATACTGTGGACTCA GCTCTTCTGCGGGCCATATCCCAGGAGAGTCAGCATCCGATCACCCTGCCCCTGCAGGCTCAGAGTTGGGCCCTGCCTACATGAGGACTGGATACATGTCTGGTTCCTCTGCAGGCTCCAAGACCAGC TGCAGGCTCTTCTGGCACCAGCTATCTTCATGGATACCTTCATAGATGCCCCGTTCTGCATCTGTGAGCACTGGCAGACAGGCCTGGGGCTCCTTCGTGTGGGTTCACCCAGGAGGCCGAAGGCCTTC TCTTCGACATTCCAGGCCAGTGAGGAACTGAAGCATCCAAGGGCCTGCCTTCCTTGTGAGAAATCATGTCTTCCCACTGCTCCCAGCGGCCTACTGGAGGCTCTGAAGATGCCAAGGGCGATGCTGTT CTGCGACCTCTAGAGGTGACAGGGAGCCTATGGCAGCTCTTTCTACTTGTGGCACTGTTCATAAACTTTAGGTCGAAGCTGAGTCAGGCCTGGCCCAGGCCCTGCATTGAAACAAGAGCCAGGGCACG GTCCACCTCAGGGCTGCAGCGGGCAGCTCTTCTGGCCTCTCCTTCGCACTCACTACACTTTAAATGCACCAAGTCCCATCTGGGGACACCTTCTGTCTCATCTAATGCAAAAACATGCAAATAAACAA AACAAGAGAAATCCCAAACCAGCCAAACCACAGTAACTTAAAACAGTCCACATCTGCCCACCAGGCAGGCTCAGCCGTCTGTCTCCACCAACCAGAAGTCAGGCTGGAGTCATCTTGAGTGTGGCATG TGACACAGGTTGCTGGCTGGGAGCCCCGAGTCTTTACTGGGACAGCTGGCTGGGGCTCGTATTTTAGCTGTGTTATAGGGGGACCACCCAGAGAGGAGAAAGTGAGGAGACACAAGCCAGCAGAGACA GTCTGTAGACTGTTCAGAACAGGCCTTAAGGCCACACAGTATGGCTTCTACCACCTTCCACCGCACCCTTGTGCATACCATACAGCCCACCACCGCTGAGGCCCTGTCTTCACTGCAAAGATCTTCGT AGCTTCCGAAGATGCAGTGAAAAGCTCTTACTCCCGGACCTGAGGACTGAAGCAGTGAGCACCAGACAGTGGAGTGTTCTCTCCTGCTGCCTTGCTGCATCCTGGGAGCATCTCTGTAGCCAAGGTGG CCAGCCTTGGCTGCAGCTAGCCCAAAGAGCTTGGCAGCACCTGCGCCATTGTTCCTGTTTTCTCTGGCCACCACCTTTGAGCTCAGGCACCATTGATCCCTCCATCTGGACGGTGACAGCTTGCTTTC ATGTCTTGGCAGAGGGAGCTGTCTGTGTGACTCCAGCATGCCAGCCCTGATGCCAGCAGGACTGGCATGTCCCAGGAGGTGGGAACTGGGCTAGAGGGCCTGGGGTCGGGGGTCAGGGGTCATGGCCT CTCGGAGGTGATTCTTGAAGAGGATCCTGCTGCAGCTCTTTACATAAGACCTGATAGGGCATCAGGCTCAGCGGTGGCACATGGAAGTCCCATGTATGTGACCACAAGGGGACAGCACTGAGGCACTC TCCAAGGCAGGCACCTGCTGTACCTCTGCTTTGATCTGTCTGGAGATGCCAAAATGCCTCTCATTGCTGTGTTGATGCCTGTCATCTTAATGAGTTGATTAGGTGAAGGCAGGGACATAGTAAATGCT CAACAAACCTCA
hide sequence
RefSeq Acc Id:
NM_053529 ⟹ NP_445981
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 5,647,085 - 5,694,342 (-) NCBI mRatBN7.2 10 5,140,178 - 5,187,440 (-) NCBI Rnor_6.0 10 5,213,350 - 5,260,608 (-) NCBI Rnor_5.0 10 4,036,437 - 4,083,966 (-) NCBI RGSC_v3.4 10 5,087,174 - 5,133,418 (-) RGD Celera 10 4,158,435 - 4,205,434 (-) NCBI
Sequence:
GCAGAGGTTCCTGGGTCTCACTTCATGTTTTGGATTCTGCGAGACTGGATGAGAGGCGGCTGGC CTGCCTCAGAGCACTGCCATGAACCACTTCCAGGCCATCCTGGCCCAGGTGCAGACACTGCTGTCCAGTCAGCAGCCCAGGCAGGTGCGGGCCCTCCTGGATGGCTTGCTGGAAGAAGAGCTGCTCTC ACGGGAATACCATTGTGCCCTGCTTCATGAGCCTGATGGTGAGGCTCTGGCCCGGAAGATTTCCCTCACCTTGCTGGAGAAAGGGGACCTGGACTTGGCGTTTGTGAGCTGGGTTTGCAACAGGCTGC AGGTCCCTGAGGTAGAGAGGGGCCCCAACTGCAGGGACCATGGAGGCCATACTCTGTGTGCCACCATGGAGCTGGGGTCTCCAGAGGGCAGCTACCTGGAGCTCCTTAACAGTGATGCTGACCCCCTA CACCTCTACCACCTCTATGACCAGATGGACCTTGCTGGGGAGGAAGAGATCGAACTCAACTCAGAGACAGACATGGACACCATCAACTGTGACCAGTTCAGCAAGCTGTTGCAGGATATGGAAATGGA TGAAGAGACCCGGGAGGCCTATGCCAATATCGCGGAACTGGATCAGTACGTGTTCCAGGATACCCAGCTGGAGGGCCTGAGCAAGGACCTCTTCATACAGCACATTGGACCAGAGGAAGGCTTTGGTG AGAACGTAGAGGGCCCTGCAGAATCAGGAGAGAAGCCTCAGAAGAGACGCTTCCCAGAAGAGCATGCTATGGACTCAAAGCACAGGAAACTAGTGCCTCCCTCTAGGACCTCACTGAACTATTTGGAT CTCCCCGCTGGGCATATCCAGATCTTCACCACTCTGCCCCAGGGACTCTGGCAAATCTCAGGGGTTGGCACAGGGCTCTCCAGTGTCCTAGTCTACCACGGTGAGATGCCCCAGGTCAACCAATTACT CTCTTCAAGCAGCCCCACTGTCCCCAGTCTCCCCGAGTCCCCAGACCGGCCTGGCTCCACCAGCCCCTTCGCGCCATCCACAGCTGACCTGCCCGGCATGCCTGAACCTGCTCTGACCTCCCGTGTAA ATGAGACAGAGGACACAACACCCCCCTCCCCATGCCAAGAGGATCCCGAGCCTTCCATCAAGCTTCCAAAATGGCCAGAGTCCGTGGAGCGGTTCCAGCACTCCCTACAGGACAAGTACCAAGCACTG CCCGGGAGCCCAAGTGGTCCTCTGGTAGCCATGGAGCTGGTGCGGGCCAGGTTGGAAAGAGGTAGCAACAAGAGTCAGGAAAGGGAGCTGGCCACTCCTGACTGGACAGAGCGCCAGCTAGCCCATGG CGGTCTGGCCGAGGTACTTCGGGTTGTCGGCGACTCCAGGAGATCACGAGAGACACAGGTGGTCGCTGTGCTGGGCAAGGCTGGTCAGGGCAAGAGCCACTGGGCCAGGACAGTGAGCCACATTTGGG CACAAGGCCAGTTACCACAATATGACTTTGTCTTCTACGTCCCCTGTCAATGCTTGGATCGCCCTGGGGACACCTACCACCTGCGGGATCTGCTCTGTCCCCCGAACCTGCAGCCACTGGCCATGGAT GACGAGGTCATTGATCATATTGTGAGGCAGCCGGACCGTGTTCTGCTCATCCTAGATGCTTTTGAGGAGCTAGAGGCCCAAGACAGCCTCCTGCATGGACCCTGTGGACCTCTGTCCCCAGAGCCCTG CTCCCTCCGGGGACTGCTGGCTGGGCTCTTCCAGCGTAAGCTGCTGCGAGGCTGCACCCTGCTCCTCACAGCCCGGCCCCGGGGCCGCCTGGCTCAGAGCCTGAGCAAGGCAGATGCCATCTTCGAGG TGCCCAGCTTCTCTACGAAACAGGCCCAGATCTATATGAGGCACTACTTTGAGAACTCAGGGACAGCAGGGAGTCACGACAAGGCCCTGGGCCTCCTGGAGGGCCAGCCTTTTCTCCTCACCCACAGT CACAGCCCTGTTCTGTGCAGTGCCGTGTGTCAGCTCTCCAAGGCCCTGCTGGATCAGGGCGCAGAGGCCCAGCTACCTTGCACACTCACAGGACTCTATGTTGGCCTGCTAGGCCCTGCAGCTCAGAA CAGTCCTCCTGGAGCCTTAGTTGAGTTGGCCAAGCTAGCCTGGGAGCTGGGACGGAGGCACCAAAGCACCTTGCAGGAAACCCAGTTTCCATCCGTGGAAGTGAAGACCTGGGCTGTGGCCCAAGGCT TGATGCAGCAGACCACAGAGGCCCAACTGGCTTTCTCCAGTTTTCTGCTACAGTGCTTCCTGGGTGCTGTGTGGCTGGCACAGTGCAATGAGATGAAAGACAAGGAGCTGCCACAGTACCTGGCCTTG ACCCCGAGGAAGAAGCGACCCTATGACAACTGGCTGGAGGGCGTACCACGCTTTCTGGCTGGCTTAGTTTTCCAGCCTCGAGCCCACTGCCTGGGAGCTCTGGTGGAGCCTGCAATGGCTGCAGTGGC AGATAGGAAACGGAAGGTTCTTACCAGGTACCTGAAGCGCTTGAAGCTGGGGACACTTCGGGCCGGGAGGTTGCTGGAGCTGCTACACTGTGCCCACGAAACACAGGAACCTGGTATTTGGAAGCATG TTTCACACCAGCTCCCAGGGCACCTCTCCTTCCTGGGCACACGGCTCACAGCCCCAGATGTGTATGTTCTGGGCAGGGCCTTGGAGACAGCCAGCCAGGACTTCTCCTTGGACCTTCGTCAGACTGGC ATCGAGCCCTCCAGACTGGGAGACCTCGTGGGACTCAGCTGTGTCACCAGTTTCAGGGCCTCCTTGAGTGACACAATGGCATTATGGGAGTCCCTACAGCATCAGGGAGAAACCCAGCTACTCCAGGC GGCAGAGGAGAAGTTCACCATTGAGCCATTTAAGGCCAAATCCCCAAAGGATGTGGAAGACCTGGACAGCCTTGTGCAGACCCAGAGGCTGAGAAACCCCTCAGCGGATGCAGCCAAGGATCTTCCTG CCATCCGGGACCTTAAGAAGCTAGAGTTTGCATTGGGCCCCGTCTTGGGCCCGCAGGCTTTCCCCACACTGGCCAAGATCCTTCCAGCATTCTCTTCCCTGCAGCACCTGGACCTGGACTCACTTAGC GAGAACAAGATCGGGGACAAGGGTGTGTCGAAGCTCTCAGCCACCTTCCCTCAGCTGAAGGCCCTGGAGACGCTCAACCTGTCCCAGAATAGCATCACCGATGTGGGAGCTTGCAAGCTTGCAGAAGC CCTGCCGGCCCTGGCCAAGTCCCTCCTAAGGCTGAGCTTGTACAACAACTGCATCTGTGACGAAGGGGCCAAGAGCCTGGCACGAGTGCTTCCAGACATGGTGTCCCTCCGGGTGATGGATGTCCAGT TCAACAAGTTCACGGCTGTCGGGGCCCAGCAGCTGACCTCCAGCCTTCAGAAGTGCCCTCAGGTGGAGACACTGGCAATGTGGACACCCACTATCCCCTTTGGGGTCCAGGAACACCTGCAGCAGCTG GATGCCCGGATTAGCCTGAGATGACCCTGCTGTACCCTGGACAAGCCGTACTCTGGGACACTGACCATGCTGGACCTTGAACTGGATACTGTGGACTCAGCTCTTCTGCGGGCCATATCCCAGGAGAG TCAGCATCCGATCACCCTGCCCCTGCAGGCTCAGAGTTGGGCCCTGCCTACATGAGGACTGGATACATGTCTGGTTCCTCTGCAGGCTCCAAGACCAGCTGCAGGCTCTTCTGGCACCAGCTATCTTC ATGGATACCTTCATAGATGCCCCGTTCTGCATCTGTGAGCACTGGCAGACAGGCCTGGGGCTCCTTCGTGTGGGTTCACCCAGGAGGCCGAAGGCCTTCTCTTCGACATTCCAGGCCAGTGAGGAACT GAAGCATCCAAGGGCCTGCCTTCCTTGTGAGAAATCATGTCTTCCCACTGCTCCCAGCGGCCTACTGGAGGCTCTGAAGATGCCAAGGGCGATGCTGTTCTGCGACCTCTAGAGGTGACAGGGAGCCT ATGGCAGCTCTTTCTACTTGTGGCACTGTTCATAAACTTTAGGTCGAAGCTGAGTCAGGCCTGGCCCAGGCCCTGCATTGAAACAAGAGCCAGGGCACGGTCCACCTCAGGGCTGCAGCGGGCAGCTC TTCTGGCCTCTCCTTCGCACTCACTACACTTTAAATGCACCAAGTCCCATCTGGGGACACCTTCTGTCTCATCTAATGCAAAAACATGCAAATAAACAAAACAAGAGAAATCCCAAACCAGCCAAACC ACAGTAACTTAAAACAGTCCACATCTGCCCACCAGGCAGGCTCAGCCGTCTGTCTCCACCAACCAGAAGTCAGGCTGGAGTCATCTTGAGTGTGGCATGTGACACAGGTTGCTGGCTGGGAGCCCCGA GTCTTTACTGGGACAGCTGGCTGGGGCTCGTATTTTAGCTGTGTTATAGGGGGACCACCCAGAGAGGAGAAAGTGAGGAGACACAAGCCAGCAGAGACAGTCTGTAGACTGTTCAGAACAGGCCTTAA GGCCACACAGTATGGCTTCTACCACCTTCCACCGCACCCTTGTGCATACCATACAGCCCACCACCGCTGAGGCCCTGTCTTCACTGCAAAGATCTTCGTAGCTTCCGAAGATGCAGTGAAAAGCTCTT ACTCCCGGACCTGAGGACTGAAGCAGTGAGCACCAGACAGTGGAGTGTTCTCTCCTGCTGCCTTGCTGCATCCTGGGAGCATCTCTGTAGCCAAGGTGGCCAGCCTTGGCTGCAGCTAGCCCAAAGAG CTTGGCAGCACCTGCGCCATTGTTCCTGTTTTCTCTGGCCACCACCTTTGAGCTCAGGCACCATTGATCCCTCCATCTGGACGGTGACAGCTTGCTTTCATGTCTTGGCAGAGGGAGCTGTCTGTGTG ACTCCAGCATGCCAGCCCTGATGCCAGCAGGACTGGCATGTCCCAGGAGGTGGGAACTGGGCTAGAGGGCCTGGGGTCGGGGGTCAGGGGTCATGGCCTCTCGGAGGTGATTCTTGAAGAGGATCCTG CTGCAGCTCTTTACATAAGACCTGATAGGGCATCAGGCTCAGCGGTGGCACATGGAAGTCCCATGTATGTGACCACAAGGGGACAGCACTGAGGCACTCTCCAAGGCAGGCACCTGCTGTACCTCTGC TTTGATCTGTCTGGAGATGCCAAAATGCCTCTCATTGCTGTGTTGATGCCTGTCATCTTAATGAGTTGATTAGGTGAAGGCAGGGACATAGTAAATGCTCAACAAACCTCA
hide sequence
RefSeq Acc Id:
XM_006245738 ⟹ XP_006245800
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 5,646,854 - 5,694,393 (-) NCBI mRatBN7.2 10 5,139,947 - 5,187,493 (-) NCBI Rnor_6.0 10 5,212,621 - 5,260,641 (-) NCBI Rnor_5.0 10 4,036,437 - 4,083,966 (-) NCBI
Sequence:
AACATTCCTAAGAAGGAAAAGGCTACACGAACAGCAGAGGTTCCTGGGTCTCACTTCATGTTTTGGATTCTGCGAGACTGGATGAGAGGCGGCTGGCCTGCCTCAGAGCACTGCCATGAACCACTTCC AGGCCATCCTGGCCCAGGTGCAGACACTGCTGTCCAGTCAGCAGCCCAGGCAGGTGCGGGCCCTCCTGGATGGCTTGCTGGAAGAAGAGCTGCTCTCACGGGAATACCATTGTGCCCTGCTTCATGAG CCTGATGGTGAGGCTCTGGCCCGGAAGATTTCCCTCACCTTGCTGGAGAAAGGGGACCTGGACTTGGCGTTTGTGAGCTGGGTTTGCAACAGGCTGCAGGTCCCTGAGGTAGAGAGGGGCCCCAACTG CAGGGACCATGGAGGCCATACTCTGTGTGCCACCATGGAGCTGGGGTCTCCAGAGGGCAGCTACCTGGAGCTCCTTAACAGTGATGCTGACCCCCTACACCTCTACCACCTCTATGACCAGATGGACC TTGCTGGGGAGGAAGAGATCGAACTCAACTCAGAGACAGACATGGACACCATCAACTGTGACCAGTTCAGCAAGCTGTTGCAGGATATGGAAATGGATGAAGAGACCCGGGAGGCCTATGCCAATATC GCGGAACTGGATCAGTACGTGTTCCAGGATACCCAGCTGGAGGGCCTGAGCAAGGACCTCTTCATACAGCACATTGGACCAGAGGAAGGCTTTGGTGAGAACGTAGAGGGCCCTGCAGAATCAGGAGA GAAGCCTCAGAAGAGACGCTTCCCAGAAGAGCATGCTATGGACTCAAAGCACAGGAAACTAGTGCCTCCCTCTAGGACCTCACTGAACTATTTGGATCTCCCCGCTGGGCATATCCAGATCTTCACCA CTCTGCCCCAGGGACTCTGGCAAATCTCAGGGGTTGGCACAGGGCTCTCCAGTGTCCTAGTCTACCACGGTGAGATGCCCCAGGTCAACCAATTACTCTCTTCAAGCAGCCCCACTGTCCCCAGTCTC CCCGAGTCCCCAGACCGGCCTGGCTCCACCAGCCCCTTCGCGCCATCCACAGCTGACCTGCCCGGCATGCCTGAACCTGCTCTGACCTCCCGTGTAAATGAGACAGAGGACACAACACCCCCCTCCCC ATGCCAAGAGGATCCCGAGCCTTCCATCAAGCTTCCAAAATGGCCAGAGTCCGTGGAGCGGTTCCAGCACTCCCTACAGGACAAGTACCAAGCACTGCCCGGGAGCCCAAGTGGTCCTCTGGTAGCCA TGGAGCTGGTGCGGGCCAGGTTGGAAAGAGGTAGCAACAAGAGTCAGGAAAGGGAGCTGGCCACTCCTGACTGGACAGAGCGCCAGCTAGCCCATGGCGGTCTGGCCGAGGTACTTCGGGTTGTCGGC GACTCCAGGAGATCACGAGAGACACAGGTGGTCGCTGTGCTGGGCAAGGCTGGTCAGGGCAAGAGCCACTGGGCCAGGACAGTGAGCCACATTTGGGCACAAGGCCAGTTACCACAATATGACTTTGT CTTCTACGTCCCCTGTCAATGCTTGGATCGCCCTGGGGACACCTACCACCTGCGGGATCTGCTCTGTCCCCCGAACCTGCAGCCACTGGCCATGGATGACGAGGTCATTGATCATATTGTGAGGCAGC CGGACCGTGTTCTGCTCATCCTAGATGCTTTTGAGGAGCTAGAGGCCCAAGACAGCCTCCTGCATGGACCCTGTGGACCTCTGTCCCCAGAGCCCTGCTCCCTCCGGGGACTGCTGGCTGGGCTCTTC CAGCGTAAGCTGCTGCGAGGCTGCACCCTGCTCCTCACAGCCCGGCCCCGGGGCCGCCTGGCTCAGAGCCTGAGCAAGGCAGATGCCATCTTCGAGGTGCCCAGCTTCTCTACGAAACAGGCCCAGAT CTATATGAGGCACTACTTTGAGAACTCAGGGACAGCAGGGAGTCACGACAAGGCCCTGGGCCTCCTGGAGGGCCAGCCTTTTCTCCTCACCCACAGTCACAGCCCTGTTCTGTGCAGTGCCGTGTGTC AGCTCTCCAAGGCCCTGCTGGATCAGGGCGCAGAGGCCCAGCTACCTTGCACACTCACAGGACTCTATGTTGGCCTGCTAGGCCCTGCAGCTCAGAACAGTCCTCCTGGAGCCTTAGTTGAGTTGGCC AAGCTAGCCTGGGAGCTGGGACGGAGGCACCAAAGCACCTTGCAGGAAACCCAGTTTCCATCCGTGGAAGTGAAGACCTGGGCTGTGGCCCAAGGCTTGATGCAGCAGACCACAGAGGCCCAACTGGC TTTCTCCAGTTTTCTGCTACAGTGCTTCCTGGGTGCTGTGTGGCTGGCACAGTGCAATGAGATGAAAGACAAGGAGCTGCCACAGTACCTGGCCTTGACCCCGAGGAAGAAGCGACCCTATGACAACT GGCTGGAGGGCGTACCACGCTTTCTGGCTGGCTTAGTTTTCCAGCCTCGAGCCCACTGCCTGGGAGCTCTGGTGGAGCCTGCAATGGCTGCAGTGGCAGATAGGAAACGGAAGGTTCTTACCAGGTAC CTGAAGCGCTTGAAGCTGGGGACACTTCGGGCCGGGAGGTTGCTGGAGCTGCTACACTGTGCCCACGAAACACAGGAACCTGGTATTTGGAAGCATGTTTCACACCAGCTCCCAGGGCACCTCTCCTT CCTGGGCACACGGCTCACAGCCCCAGATGTGTATGTTCTGGGCAGGGCCTTGGAGACAGCCAGCCAGGACTTCTCCTTGGACCTTCGTCAGACTGGCATCGAGCCCTCCAGACTGGGAGACCTCGTGG GACTCAGCTGTGTCACCAGTTTCAGGGCCTCCTTGAGTGACACAATGGCATTATGGGAGTCCCTACAGCATCAGGGAGAAACCCAGCTACTCCAGGCGGCAGAGGAGAAGTTCACCATTGAGCCATTT AAGGCCAAATCCCCAAAGGATGTGGAAGACCTGGACAGCCTTGTGCAGACCCAGAGGCTGAGAAACCCCTCAGCGGATGCAGCCAAGGATCTTCCTGCCATCCGGGACCTTAAGAAGCTAGAGTTTGC ATTGGGCCCCGTCTTGGGCCCGCAGGCTTTCCCCACACTGGCCAAGATCCTTCCAGCATTCTCTTCCCTGCAGCACCTGGACCTGGACTCACTTAGCGAGAACAAGATCGGGGACAAGGGTGTGTCGA AGCTCTCAGCCACCTTCCCTCAGCTGAAGGCCCTGGAGACGCTCAACCTGTCCCAGAATAGCATCACCGATGTGGGAGCTTGCAAGCTTGCAGAAGCCCTGCCGGCCCTGGCCAAGTCCCTCCTAAGG CTGAGCTTGTACAACAACTGCATCTGTGACGAAGGGGCCAAGAGCCTGGCACGAGTGCTTCCAGACATGGTGTCCCTCCGGGTGATGGATGTCCAGTTCAACAAGTTCACGGCTGTCGGGGCCCAGCA GCTGACCTCCAGCCTTCAGAAGTGCCCTCAGGTGGAGACACTGGCAATGTGGACACCCACTATCCCCTTTGGGGTCCAGGAACACCTGCAGCAGCTGGATGCCCGGATTAGCCTGAGATGACCCTGCT GTACCCTGGACAAGGCTGCTCCTCTGGAAGCTCACCTGCCTCTCCTGATCTCCCACAGCCGTACTCTGGGACACTGACCATGCTGGACCTTGAACTGGATACTGTGGACTCAGCTCTTCTGCGGGCCA TATCCCAGGAGAGTCAGCATCCGATCACCCTGCCCCTGCAGGCTCAGAGTTGGGCCCTGCCTACATGAGGACTGGATACATGTCTGGTTCCTCTGCAGGCTCCAAGACCAGCTGCAGGCTCTTCTGGC ACCAGCTATCTTCATGGATACCTTCATAGATGCCCCGTTCTGCATCTGTGAGCACTGGCAGACAGGCCTGGGGCTCCTTCGTGTGGGTTCACCCAGGAGGCCGAAGGCCTTCTCTTCGACATTCCAGG CCAGTGAGGAACTGAAGCATCCAAGGGCCTGCCTTCCTTGTGAGAAATCATGTCTTCCCACTGCTCCCAGCGGCCTACTGGAGGCTCTGAAGATGCCAAGGGCGATGCTGTTCTGCGACCTCTAGAGG TGACAGGGAGCCTATGGCAGCTCTTTCTACTTGTGGCACTGTTCATAAACTTTAGGTCGAAGCTGAGTCAGGCCTGGCCCAGGCCCTGCATTGAAACAAGAGCCAGGGCACGGTCCACCTCAGGGCTG CAGCGGGCAGCTCTTCTGGCCTCTCCTTCGCACTCACTACACTTTAAATGCACCAAGTCCCATCTGGGGACACCTTCTGTCTCATCTAATGCAAAAACATGCAAATAAACAAAACAAGAGAAATCCCA AACCAGCCAAACCACAGTAACTTAAAACAGTCCACATCTGCCCACCAGGCAGGCTCAGCCGTCTGTCTCCACCAACCAGAAGTCAGGCTGGAGTCATCTTGAGTGTGGCATGTGACACAGGTTGCTGG CTGGGAGCCCCGAGTCTTTACTGGGACAGCTGGCTGGGGCTCGTATTTTAGCTGTGTTATAGGGGGACCACCCAGAGAGGAGAAAGTGAGGAGACACAAGCCAGCAGAGACAGTCTGTAGACTGTTCA GAACAGGCCTTAAGGCCACACAGTATGGCTTCTACCACCTTCCACCGCACCCTTGTGCATACCATACAGCCCACCACCGCTGAGGCCCTGTCTTCACTGCAAAGATCTTCGTAGCTTCCGAAGATGCA GTGAAAAGCTCTTACTCCCGGACCTGAGGACTGAAGCAGTGAGCACCAGACAGTGGAGTGTTCTCTCCTGCTGCCTTGCTGCATCCTGGGAGCATCTCTGTAGCCAAGGTGGCCAGCCTTGGCTGCAG CTAGCCCAAAGAGCTTGGCAGCACCTGCGCCATTGTTCCTGTTTTCTCTGGCCACCACCTTTGAGCTCAGGCACCATTGATCCCTCCATCTGGACGGTGACAGCTTGCTTTCATGTCTTGGCAGAGGG AGCTGTCTGTGTGACTCCAGCATGCCAGCCCTGATGCCAGCAGGACTGGCATGTCCCAGGAGGTGGGAACTGGGCTAGAGGGCCTGGGGTCGGGGGTCAGGGGTCATGGCCTCTCGGAGGTGATTCTT GAAGAGGATCCTGCTGCAGCTCTTTACATAAGACCTGATAGGGCATCAGGCTCAGCGGTGGCACATGGAAGTCCCATGTATGTGACCACAAGGGGACAGCACTGAGGCACTCTCCAAGGCAGGCACCT GCTGTACCTCTGCTTTGATCTGTCTGGAGATGCCAAAATGCCTCTCATTGCTGTGTTGATGCCTGTCATCTTAATGAGTTGATTAGGTGAAGGCAGGGACATAGTAAATGCTCAACAAACCTCACTGG TTCTTAATCTTGTGCACTGGGAAGCATCTTACCTTCAAAGGACTACACAACACCAACTCTCGACTGAGCTGTCTGGTTTCATGCTCCATTTTGCTGCATATGCAAGGCAAGTTTCCTCTGTGCCTTAG CTTCCTTATTTGTAAAATGGGAAGAGTCATGGATCTTCTCTTCTGGGTTACGTAAAGACTCCATGTGGAAACAATATTAATAAAATGAGTCAGAAAGTGGCTGAGGGGCTAGAGCAAGCCTGGTGGCC CGAGCCTGATCCCCAGGGCCACACGATGGGAGGGGGAACCAGTGATCACAAGTTCTCTGGAAGTTTCAGTGCACTGTGTGTGCACTGGAGCTACAGGTGGTGATGAGCCTCTGTGTTGGTGCCAGGAA CAGAACTCGGGTCCCCTGCAAAGGCAGCAAGGACGCTTAATCACTGAGTCGTTTCTCTAGCCTGTTTAAACAGAAAAATTAAGAGCTGAAACCAGTGCCTGGCAGGGGTTCTGATGCCCTCTTATGGG CTCCATGGGCACTGTGTGCACTTGGTGCACACACACACAGGCAAAACACACATACATATACATAAATCTTGAAAAACACCAAGGTCATGGGTGGTAGCATACACCTTTAACCCCAGATCTCTGTGAAC TCAAGGCCAGCCTGGTCTATGTTACACAGGGAGGCACTGTCCTAACAAATAAAAACCCAGCACACAGCTCAGTGCAGGAGCTCCC
hide sequence
RefSeq Acc Id:
XM_039087000 ⟹ XP_038942928
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 5,646,854 - 5,671,320 (-) NCBI mRatBN7.2 10 5,139,947 - 5,164,416 (-) NCBI
RefSeq Acc Id:
NP_445981 ⟸ NM_053529
- Peptide Label:
isoform 1
- UniProtKB:
A6K4J3 (UniProtKB/TrEMBL), Q9GJE0 (UniProtKB/TrEMBL)
- Sequence:
MNHFQAILAQVQTLLSSQQPRQVRALLDGLLEEELLSREYHCALLHEPDGEALARKISLTLLEKGDLDLAFVSWVCNRLQVPEVERGPNCRDHGGHTLCATMELGSPEGSYLELLNSDADPLHLYHLY DQMDLAGEEEIELNSETDMDTINCDQFSKLLQDMEMDEETREAYANIAELDQYVFQDTQLEGLSKDLFIQHIGPEEGFGENVEGPAESGEKPQKRRFPEEHAMDSKHRKLVPPSRTSLNYLDLPAGHI QIFTTLPQGLWQISGVGTGLSSVLVYHGEMPQVNQLLSSSSPTVPSLPESPDRPGSTSPFAPSTADLPGMPEPALTSRVNETEDTTPPSPCQEDPEPSIKLPKWPESVERFQHSLQDKYQALPGSPSG PLVAMELVRARLERGSNKSQERELATPDWTERQLAHGGLAEVLRVVGDSRRSRETQVVAVLGKAGQGKSHWARTVSHIWAQGQLPQYDFVFYVPCQCLDRPGDTYHLRDLLCPPNLQPLAMDDEVIDH IVRQPDRVLLILDAFEELEAQDSLLHGPCGPLSPEPCSLRGLLAGLFQRKLLRGCTLLLTARPRGRLAQSLSKADAIFEVPSFSTKQAQIYMRHYFENSGTAGSHDKALGLLEGQPFLLTHSHSPVLC SAVCQLSKALLDQGAEAQLPCTLTGLYVGLLGPAAQNSPPGALVELAKLAWELGRRHQSTLQETQFPSVEVKTWAVAQGLMQQTTEAQLAFSSFLLQCFLGAVWLAQCNEMKDKELPQYLALTPRKKR PYDNWLEGVPRFLAGLVFQPRAHCLGALVEPAMAAVADRKRKVLTRYLKRLKLGTLRAGRLLELLHCAHETQEPGIWKHVSHQLPGHLSFLGTRLTAPDVYVLGRALETASQDFSLDLRQTGIEPSRL GDLVGLSCVTSFRASLSDTMALWESLQHQGETQLLQAAEEKFTIEPFKAKSPKDVEDLDSLVQTQRLRNPSADAAKDLPAIRDLKKLEFALGPVLGPQAFPTLAKILPAFSSLQHLDLDSLSENKIGD KGVSKLSATFPQLKALETLNLSQNSITDVGACKLAEALPALAKSLLRLSLYNNCICDEGAKSLARVLPDMVSLRVMDVQFNKFTAVGAQQLTSSLQKCPQVETLAMWTPTIPFGVQEHLQQLDARISL R
hide sequence
RefSeq Acc Id:
NP_001257732 ⟸ NM_001270803
- Peptide Label:
isoform 2
- UniProtKB:
A0A0G2K9Q5 (UniProtKB/TrEMBL), A6K4J5 (UniProtKB/TrEMBL), Q9GJD9 (UniProtKB/TrEMBL)
- Sequence:
MRCQVPGPSGSYLQGHTLCATMELGSPEGSYLELLNSDADPLHLYHLYDQMDLAGEEEIELNSE TDMDTINCDQFSKLLQDMEMDEETREAYANIAELDQYVFQDTQLEGLSKDLFIQHIGPEEGFGENVEGPAESGEKPQKRRFPEEHAMDSKHRKLVPPSRTSLNYLDLPAGHIQIFTTLPQGLWQISGV GTGLSSVLVYHGEMPQVNQLLSSSSPTVPSLPESPDRPGSTSPFAPSTADLPGMPEPALTSRVNETEDTTPPSPCQEDPEPSIKLPKWPESVERFQHSLQDKYQALPGSPSGPLVAMELVRARLERGS NKSQERELATPDWTERQLAHGGLAEVLRVVGDSRRSRETQVVAVLGKAGQGKSHWARTVSHIWAQGQLPQYDFVFYVPCQCLDRPGDTYHLRDLLCPPNLQPLAMDDEVIDHIVRQPDRVLLILDAFE ELEAQDSLLHGPCGPLSPEPCSLRGLLAGLFQRKLLRGCTLLLTARPRGRLAQSLSKADAIFEVPSFSTKQAQIYMRHYFENSGTAGSHDKALGLLEGQPFLLTHSHSPVLCSAVCQLSKALLDQGAE AQLPCTLTGLYVGLLGPAAQNSPPGALVELAKLAWELGRRHQSTLQETQFPSVEVKTWAVAQGLMQQTTEAQLAFSSFLLQCFLGAVWLAQCNEMKDKELPQYLALTPRKKRPYDNWLEGVPRFLAGL VFQPRAHCLGALVEPAMAAVADRKRKVLTRYLKRLKLGTLRAGRLLELLHCAHETQEPGIWKHVSHQLPGHLSFLGTRLTAPDVYVLGRALETASQDFSLDLRQTGIEPSRLGDLVGLSCVTSFRASL SDTMALWESLQHQGETQLLQAAEEKFTIEPFKAKSPKDVEDLDSLVQTQRLRNPSADAAKDLPAIRDLKKLEFALGPVLGPQAFPTLAKILPAFSSLQHLDLDSLSENKIGDKGVSKLSATFPQLKAL ETLNLSQNSITDVGACKLAEALPALAKSLLRLSLYNNCICDEGAKSLARVLPDMVSLRVMDVQFNKFTAVGAQQLTSSLQKCPQVETLAMWTPTIPFGVQEHLQQLDARISLR
hide sequence
RefSeq Acc Id:
NP_001257733 ⟸ NM_001270804
- Peptide Label:
isoform 3
- UniProtKB:
A6K4J8 (UniProtKB/TrEMBL), Q9GJD8 (UniProtKB/TrEMBL)
- Sequence:
MELGSPEGSYLELLNSDADPLHLYHLYDQMDLAGEEEIELNSETDMDTINCDQFSKLLQDMEMDEETREAYANIAELDQYVFQDTQLEGLSKDLFIQHIGPEEGFGENVEGPAESGEKPQKRRFPEEH AMDSKHRKLVPPSRTSLNYLDLPAGHIQIFTTLPQGLWQISGVGTGLSSVLVYHGEMPQVNQLLSSSSPTVPSLPESPDRPGSTSPFAPSTADLPGMPEPALTSRVNETEDTTPPSPCQEDPEPSIKL PKWPESVERFQHSLQDKYQALPGSPSGPLVAMELVRARLERGSNKSQERELATPDWTERQLAHGGLAEVLRVVGDSRRSRETQVVAVLGKAGQGKSHWARTVSHIWAQGQLPQYDFVFYVPCQCLDRP GDTYHLRDLLCPPNLQPLAMDDEVIDHIVRQPDRVLLILDAFEELEAQDSLLHGPCGPLSPEPCSLRGLLAGLFQRKLLRGCTLLLTARPRGRLAQSLSKADAIFEVPSFSTKQAQIYMRHYFENSGT AGSHDKALGLLEGQPFLLTHSHSPVLCSAVCQLSKALLDQGAEAQLPCTLTGLYVGLLGPAAQNSPPGALVELAKLAWELGRRHQSTLQETQFPSVEVKTWAVAQGLMQQTTEAQLAFSSFLLQCFLG AVWLAQCNEMKDKELPQYLALTPRKKRPYDNWLEGVPRFLAGLVFQPRAHCLGALVEPAMAAVADRKRKVLTRYLKRLKLGTLRAGRLLELLHCAHETQEPGIWKHVSHQLPGHLSFLGTRLTAPDVY VLGRALETASQDFSLDLRQTGIEPSRLGDLVGLSCVTSFRASLSDTMALWESLQHQGETQLLQAAEEKFTIEPFKAKSPKDVEDLDSLVQTQRLRNPSADAAKDLPAIRDLKKLEFALGPVLGPQAFP TLAKILPAFSSLQHLDLDSLSENKIGDKGVSKLSATFPQLKALETLNLSQNSITDVGACKLAEALPALAKSLLRLSLYNNCICDEGAKSLARVLPDMVSLRVMDVQFNKFTAVGAQQLTSSLQKCPQV ETLAMWTPTIPFGVQEHLQQLDARISLR
hide sequence
RefSeq Acc Id:
XP_006245800 ⟸ XM_006245738
- Peptide Label:
isoform X1
- UniProtKB:
A6K4J3 (UniProtKB/TrEMBL), Q9GJE0 (UniProtKB/TrEMBL)
- Sequence:
MNHFQAILAQVQTLLSSQQPRQVRALLDGLLEEELLSREYHCALLHEPDGEALARKISLTLLEK GDLDLAFVSWVCNRLQVPEVERGPNCRDHGGHTLCATMELGSPEGSYLELLNSDADPLHLYHLYDQMDLAGEEEIELNSETDMDTINCDQFSKLLQDMEMDEETREAYANIAELDQYVFQDTQLEGLS KDLFIQHIGPEEGFGENVEGPAESGEKPQKRRFPEEHAMDSKHRKLVPPSRTSLNYLDLPAGHIQIFTTLPQGLWQISGVGTGLSSVLVYHGEMPQVNQLLSSSSPTVPSLPESPDRPGSTSPFAPST ADLPGMPEPALTSRVNETEDTTPPSPCQEDPEPSIKLPKWPESVERFQHSLQDKYQALPGSPSGPLVAMELVRARLERGSNKSQERELATPDWTERQLAHGGLAEVLRVVGDSRRSRETQVVAVLGKA GQGKSHWARTVSHIWAQGQLPQYDFVFYVPCQCLDRPGDTYHLRDLLCPPNLQPLAMDDEVIDHIVRQPDRVLLILDAFEELEAQDSLLHGPCGPLSPEPCSLRGLLAGLFQRKLLRGCTLLLTARPR GRLAQSLSKADAIFEVPSFSTKQAQIYMRHYFENSGTAGSHDKALGLLEGQPFLLTHSHSPVLCSAVCQLSKALLDQGAEAQLPCTLTGLYVGLLGPAAQNSPPGALVELAKLAWELGRRHQSTLQET QFPSVEVKTWAVAQGLMQQTTEAQLAFSSFLLQCFLGAVWLAQCNEMKDKELPQYLALTPRKKRPYDNWLEGVPRFLAGLVFQPRAHCLGALVEPAMAAVADRKRKVLTRYLKRLKLGTLRAGRLLEL LHCAHETQEPGIWKHVSHQLPGHLSFLGTRLTAPDVYVLGRALETASQDFSLDLRQTGIEPSRLGDLVGLSCVTSFRASLSDTMALWESLQHQGETQLLQAAEEKFTIEPFKAKSPKDVEDLDSLVQT QRLRNPSADAAKDLPAIRDLKKLEFALGPVLGPQAFPTLAKILPAFSSLQHLDLDSLSENKIGDKGVSKLSATFPQLKALETLNLSQNSITDVGACKLAEALPALAKSLLRLSLYNNCICDEGAKSLA RVLPDMVSLRVMDVQFNKFTAVGAQQLTSSLQKCPQVETLAMWTPTIPFGVQEHLQQLDARISLR
hide sequence
Ensembl Acc Id:
ENSRNOP00000075087 ⟸ ENSRNOT00000085310
Ensembl Acc Id:
ENSRNOP00000069553 ⟸ ENSRNOT00000085479
Ensembl Acc Id:
ENSRNOP00000003572 ⟸ ENSRNOT00000003572
RefSeq Acc Id:
XP_038942928 ⟸ XM_039087000
- Peptide Label:
isoform X2
- UniProtKB:
Q9GJD8 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000076804 ⟸ ENSRNOT00000095982
RGD ID: 13696944
Promoter ID: EPDNEW_R7469
Type: single initiation site
Name: Ciita_1
Description: class II, major histocompatibility complex, transactivator
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 10 5,260,589 - 5,260,649 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-04-07
Ciita
class II transactivator
C2ta
class II, major histocompatibility complex, transactivator
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2005-11-17
C2ta
class II, major histocompatibility complex, transactivator
Mhc2ta
MHC class II transactivator
Symbol and Name updated
1299863
APPROVED
2005-01-20
Mhc2ta
MHC class II transactivator
C2ta
Symbol updated
1299863
APPROVED
2002-08-07
C2ta
MHC class II transactivator
Symbol and Name status set to provisional
70820
PROVISIONAL
Note Type
Note
Reference
gene_process
may play a role in the inflammatory response
1358146
gene_regulation
Following ventral root avulsion nerve injury, transcripts were upregulated more in DA rat than in PVG rats
1358146